COSCIENS Biopharma Inc
OTC:CSCIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
COSCIENS Biopharma Inc
OTC:CSCIF
|
CA |
|
A
|
American Express Co
XMUN:AEC1
|
US |
|
C
|
Continental Aerospace Technologies Holding Ltd
HKEX:232
|
HK |
|
U
|
Unilever PLC
F:UNVB
|
UK |
|
Agree Realty Corp
NYSE:ADC
|
US |
|
Bushveld Minerals Ltd
LSE:BMN
|
ZA |
|
I
|
Intuit Inc
F:ITU
|
US |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
F:RJ8
|
MC |
|
K
|
Kyocera Corp
F:KYRA
|
JP |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
B
|
Boeing Co
XETRA:BCO
|
US |
|
EVRAZ plc
LSE:EVR
|
UK |
|
Granules India Ltd
NSE:GRANULES
|
IN |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
J
|
Japan Pure Chemical Co Ltd
TSE:4973
|
JP |
|
M
|
Marubeni Corp
OTC:MARUF
|
JP |
|
Allianz SE
MIL:1ALV
|
DE |
|
Gurit Holding AG
F:GVM0
|
CH |
Bankruptcy Probability
COSCIENS Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
COSCIENS Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
COSCIENS Biopharma Inc
TSX:CSCI
|
11.7m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
COSCIENS Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, COSCIENS Biopharma Inc has total debt of 1.9m USD. This includes both short-term (0 USD) and long-term (1.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
